D49.2 Neoplasm of unspecified behavior of bone, soft tissue, and skin

✓ Billable ICD-10-CM 2026
Open D49.2 in Web App →

The ICD-10-CM code for Neoplasm of unspecified behavior of bone, soft tissue, and skin is D49.2 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Section
D49: Neoplasms of unspecified behavior (D49)
Category D49
18 codes (14 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to D49.2:

  • Osteitis › deformans › in (due to) › neoplastic disease › fibula
  • Osteitis › deformans › in (due to) › neoplastic disease › humerus
  • Osteitis › deformans › in (due to) › neoplastic disease › ischium
  • Osteitis › deformans › in (due to) › neoplastic disease › femur
  • Osteitis › deformans › in (due to) › neoplastic disease › clavicle
  • Osteitis › deformans › in (due to) › neoplastic disease › ilium
  • Osteitis › deformans › in (due to) › neoplastic disease › carpus
  • Osteitis › deformans › in (due to) › neoplastic disease › finger
Excludes1
Not coded here. These conditions should NOT be coded together with D49.2.
  • neoplasm of unspecified behavior of anal canal (D49.0)
  • neoplasm of unspecified behavior of anus NOS (D49.0)
  • neoplasm of unspecified behavior of bone marrow (D49.89)
  • neoplasm of unspecified behavior of cartilage of larynx (D49.1)
  • neoplasm of unspecified behavior of cartilage of nose (D49.1)
  • neoplasm of unspecified behavior of connective tissue of breast (D49.3)
  • neoplasm of unspecified behavior of skin of genital organs (D49.59)
  • neoplasm of unspecified behavior of vermilion border of lip (D49.0)

U.S. Hospital Utilization

  • An estimated 2,445 U.S. inpatient stays in 2023 included D49.2 among the documented diagnoses.
  • 615 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Related Codes

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial